![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PMC:7652766 / 111625-111854
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"4109","span":{"begin":28,"end":36},"obj":"Species"},{"id":"4124","span":{"begin":187,"end":189},"obj":"Gene"},{"id":"4126","span":{"begin":196,"end":205},"obj":"Species"},{"id":"4127","span":{"begin":98,"end":110},"obj":"Chemical"}],"attributes":[{"id":"A4109","pred":"tao:has_database_id","subj":"4109","obj":"Tax:1335626"},{"id":"A4124","pred":"tao:has_database_id","subj":"4124","obj":"Gene:6999"},{"id":"A4126","pred":"tao:has_database_id","subj":"4126","obj":"Tax:11309"},{"id":"A4127","pred":"tao:has_database_id","subj":"4127","obj":"MESH:C041747"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gy and efficiently reducing MERS-CoV replication.\nOriginally developed as an antiprotozoal agent, nitazoxanide is another broad-spectrum antiviral agent that has been currently developed to treat influenza and other viral respira"}